| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |